PhRMA joins Mer­ck and BMS in su­ing over Medicare drug price ne­go­ti­a­tions

The phar­ma in­dus­try’s pow­er­ful lob­by­ing group is su­ing the fed­er­al gov­ern­ment af­ter a sting­ing de­feat on Capi­tol Hill last year and be­fore CMS can be­gin im­ple­ment­ing what PhRMA calls dam­ag­ing drug price set­ting that could harm fu­ture in­no­va­tion and pa­tients.

Filed in dis­trict court in west Texas to­day, along­side the Na­tion­al In­fu­sion Cen­ter As­so­ci­a­tion and the Glob­al Colon Can­cer As­so­ci­a­tion, PhRMA seeks to stop the en­force­ment of the price ne­go­ti­a­tions, which will be­gin in earnest this Sep­tem­ber, and the ex­cise tax, which it says is un­con­sti­tu­tion­al.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER